NRX PHARMACEUTICALS INC (NRXP): Institutional Ownership
Hedge funds and institutional managers reporting a position in NRXP · Health Care. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
5
13F filers
Aggregate Value
$611K
Across holders
Last Price
$3.73
2026-06-26
Sector
Health Care
GICS
Holder activity3 new0 added2 reduced
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC CIK 0001037389 | Hedge Fund | 128K | $423K | 69.2% | 0.0% | New | — | Q3 2025 |
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 25K | $53K | 8.6% | 0.0% | Reduced | $-24K | Q1 2026 |
| TWO SIGMA INVESTMENTS, LP CIK 0001179392 | Hedge Fund | 17K | $47K | 7.7% | 0.0% | Reduced | $-95K | Q4 2025 |
| MARSHALL WACE, LLP CIK 0001318757 | Hedge Fund | 14K | $46K | 7.5% | 0.0% | New | — | Q3 2025 |
| Schonfeld Strategic Advisors LLC CIK 0001665241 | Hedge Fund | 20K | $42K | 6.9% | 0.0% | New | — | Q1 2026 |
New
Hedge Fund
$423K· 69.2% of total· 0.0% port· 128K sh· — QoQ· Q3 2025
Reduced
Hedge Fund
$53K· 8.6% of total· 0.0% port· 25K sh· $-24K QoQ· Q1 2026
Reduced
Hedge Fund
$47K· 7.7% of total· 0.0% port· 17K sh· $-95K QoQ· Q4 2025
New
Hedge Fund
$46K· 7.5% of total· 0.0% port· 14K sh· — QoQ· Q3 2025
New
Hedge Fund
$42K· 6.9% of total· 0.0% port· 20K sh· — QoQ· Q1 2026